Zefylti will be available as 30 MU/0.5 mL and 48 MU/0.5 mL and is intended for the treatment of neutropenia and the mobilisation of peripheral progenitor cells
The successful completion of RRA assessment by the USFDA, would enable company to open up its business in the USA market
The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
This product is indicated in coagulation disorders caused by vitamin K deficiency or interference with vitamin K activity.
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily single-pill regimen
Aims to become India’s leading cancer testing company
Venus Remedies secures marketing authorization in Philippines
Subscribe To Our Newsletter & Stay Updated
